ACL

AUCLINICAL FPO [ACL]
Australian Clinical Labs Limited provides pathology diagnostic services in Australia. The company offers cardiac testing, gastroenterology, haematology, chemical pathology, antenatal testing, serology and microbiology, cervical screening, commercial drug and alcohol testing, STI Testing, veterinary pathology, molecular cancer services, clinical trials pathology, advanced genetic testing, functional pathology, histopathology and cytopathology, CPD education programs for clinicians, and allergy and immunology services. It also provides workplace services, environmental screening, and clinical trial services. The company offers its services under the SunDoctors, SouthernSun Pathology, Specialised Trials, BeFunctional Labs, and Gribbles Veterinary Pathology brands. It serves doctors, patients, and corporate clients. The company was founded in 2015 and is headquartered in Clayton, Australia.
Healthcare · ASX Small Cap
$2.7100 +0.0%

Updated 3 Sep 2026 · Signals refresh every scan

Appeared in 2 consecutive scansFirst seen: 2026-03-13
Get alerts when ACL triggers a new signal
Free watchlist with daily scans for 2,200+ ASX stocks
Track ACL — Free

Active Signals

Bullish Signals

  • MACD momentum is losing steam
  • Drifting lower — down 3.2% over the last 5 days
  • Beating the Small Ords index — relative strength of 1.16, so it's outpacing the pack
  • Trading above the 200-day average — the long-term trend is on your side
  • Cash positive / operating cashflow positive
  • Low P/S ratio (0.7x)
  • EPS estimates revised upward (+10pts)
  • CANSLIM I: Institutional ownership (91%)
  • Sentiment is mixed — no strong consensus either way
  • The bigger volume days are the up days — volume-weighted momentum is positive (2.50%/day)
  • Altman Z-Score grey zone (2.21, low-confidence approx)
  • RBA hiking (-3pts)

Risk Signals

  • Earnings declining (-12% QoQ)
  • Not enough chatter to gauge sentiment — defaulting to neutral
Ask Scout AI about ACL
"What's driving ACL today?" "How does ACL compare to peers?" "Key risks for ACL?"
3 free messages/day · Unlimited with Pro

Recent Catalysts

NONE Initial Director's Interest Notice - G Horan
NONE Final Director's Interest Notice - M McGrath
NONE Notification regarding unquoted securities - ACL
Announcement tone +3pts

Recent ASX Announcements

2026-08-31 Initial Director's Interest Notice - G Horan
2026-08-31 Final Director's Interest Notice - M McGrath
2026-08-31 Notification regarding unquoted securities - ACL
2026-08-31 Notification regarding unquoted securities - ACL
2026-08-31 Notification of cessation of securities - ACL

Key Metrics

$505.5M
Market Cap
1.1M
Avg Volume
0.7x
Vol Ratio
$1.83 — $3.03
52-Week Range
5.0%
Short Interest
N/A
Cash Runway
14.9%
ROE
3.2%
Profit Margin

CANSLIM Analysis

FactorRatingDetail
CCurrent EPSdecliningEPS Growth: -12%
AAnnual EarningsfailCAGR: 0%
NNew Highs / Catalystsneutral
SSupply & DemandneutralFloat: 92%
LLeader vs LaggardpassRS: 13
IInstitutional SponsorshippassInst: 91%
MMarket DirectionneutralNeutral

Sector: Healthcare

113 tickers in this sector

View all Healthcare signals →Browse all ASX tickers A–Z →
Related Tickers
REG -27.0%CAN +25.0%BIT -20.0%MEM +20.0%CMP -14.6%
Compare:ACL vs REGACL vs CANACL vs BIT
Scout Pro — Deeper Analysis for ACL
Try Pro free for 30 days
Share this analysis

Track ACL and 2,200+ ASX stocks

Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and exit management for every ASX small cap.

Open Dashboard — Free Free Screener
No credit card required